Feasibility of risk assessment in inspection and enforcement activity in cobalt therapy

Main Article Content

Ofelia M. Fornet Rodríguez
Francisco Pérez González
Antonio Torres Valle
María del C. Sánchez Pérez

Abstract

The main objective of the present work was to assess the increased radiological risk due to the deficiencies detected during the regulatory inspections of Cobaltotherapy services. The method used was the Risk Matrix, developed by the Ibero-American Forum of Regulatory Bodies, through which the relationship of the deficiencies found with the deterioration of the barriers and frequency and consequences reductors described in the practice risk model was studied. As a result of the work, the heterogeneous contribution of the deficiencies was found in a considerable number of initiating events of the stated model. The analysis carried out demonstrates the feasibility of applying this method in evaluating the impact of the deficiencies detected, as well as its support in the grouping of the recommended coercive actions to compensate those deficiencies with the greatest impact on the general state of the security of the service. Risk monitoring, based on the impact of defense measures as a consequence of the impact of deficiencies detected during regulatory inspections, is a useful resource for the inspector, who finds in it a scientific support that relates the regulations to be applied with the computerized code capabilities based on risk matrix. This makes it possible to optimize decision-making, which is important, both for the inspector and for the regulated entity. The use of the suggested methodology would make it possible to reduce the dependence on the inspector's expertise during inspections, a criterion that has traditionally prevailed in this activity.

Article Details

How to Cite
Fornet Rodríguez, O. M., Pérez González, F., Torres Valle, A., & Sánchez Pérez, M. del C. (2022). Feasibility of risk assessment in inspection and enforcement activity in cobalt therapy. Nucleus, (70). Retrieved from http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/750
Section
Ciencias Nucleares

References

[1]. Organismo Internacional de Energía Atómica. Guía para autorización e inspección: radioterapia RLA/9/064 - ATS 1. Julio, 2011.
[2]. DUMÉNIGO C, BOSCH R, DE LA FUENTE A, PÉREZ Y, QUEVEDO JR. Estimaciones de riesgo con el uso de SEVRRA. Análisis de resultados. La perspectiva del usuario y del regulador. XI
[3]. Congreso Regional de Seguridad Radiológica y Nuclear. Congreso Regional IRPA. Cuba. 2018.
[4]. TORRES A., ALFONSO R. Matriz de riesgo y FMEA acoplados para análisis de seguridad de prácticas médicas con radiaciones ionizantes. XI Congreso Regional de Seguridad Radiológica y Nuclear. Congreso Regional IRPA. Cuba. 2018.
[5]. DUMÉNIGO C, LÓPEZ R, RAMÍREZ ML, PAPADOPULOS SM, MORALES J, et. al. Metodología de matrices de riesgo. Actualización de la misma basada en las experiencias en su aplicación. XI Congreso Regional de Seguridad Radiológica y Nuclear. Congreso Regional IRPA, Cuba. 2018.
[6]. TORRES A. Programa de análisis de riesgo basado en FMEA y matriz de riesgo. SECURE-MR-FMEA. Ver. 3.0. Manual de usuario. 2020
[7]. FORO. Quick manual of SEVRRA 2.5 (FOR USB MEMORY). 2017.
[8]. SOLER K, DUMÉNIGO C, SALOMÓN J. Enfoque regulador basado en la prescripción e informado en el Riesgo [tesis para optar título de maestría]. InSTEC. La Habana. 2011.
[9]. TORRES A, RIVERO J, MONTES DE OCA J, MARTÍ O, GUTIÉRREZ J. Monitoreo dinámico de riesgo empleando matriz de riesgo en prácticas médicas con radiaciones ionizantes. Nucleus. 2016; (59): 29-33.
[10]. CITMA. Reglamento sobre notificación y autorización de prácticas y actividades asociadas al empleo de fuentes de radiaciones ionizantes. Resolución 334/11. 2011.
[11]. CNSN. Guía de Seguridad para la práctica de Radioterapia. Resolución 41/2011. La Habana, 2011.
[12]. International Atomic Energy Agency (IAEA). Aplicación del método de la matriz de riesgo a la radioterapia. IAEA-TECDOC 1685. Vienna: IAEA, 2012.
[13]. AMADOR Z, TORRES A. Uso del Código SECURE-MR-FMEA para el análisis de riesgo radiológico en medicina nuclear terapéutica convencional. Health Med Sci. 2018; 4(3): 173-181.